Last reviewed · How we verify
Routine sedation and analgesia
Routine sedation and analgesia is a Small molecule drug developed by Peking University First Hospital. It is currently FDA-approved for Sedation and analgesia during medical procedures, Sedation and analgesia in intensive care unit patients.
Routine sedation and analgesia refers to a clinical practice combining sedative and pain-relieving agents to reduce patient consciousness and discomfort during medical procedures or in intensive care settings.
Routine sedation and analgesia refers to a clinical practice combining sedative and pain-relieving agents to reduce patient consciousness and discomfort during medical procedures or in intensive care settings. Used for Sedation and analgesia during medical procedures, Sedation and analgesia in intensive care unit patients.
At a glance
| Generic name | Routine sedation and analgesia |
|---|---|
| Sponsor | Peking University First Hospital |
| Modality | Small molecule |
| Therapeutic area | Anesthesia/Critical Care |
| Phase | FDA-approved |
Mechanism of action
This is a therapeutic approach rather than a single drug entity, typically involving combinations of sedatives (such as benzodiazepines or propofol) and analgesics (such as opioids) administered to achieve desired levels of sedation and analgesia. The agents work through different mechanisms—sedatives enhance GABAergic neurotransmission or act on other CNS pathways to reduce consciousness, while analgesics modulate pain perception through opioid receptors or other pain pathways.
Approved indications
- Sedation and analgesia during medical procedures
- Sedation and analgesia in intensive care unit patients
Common side effects
- Respiratory depression
- Hypotension
- Bradycardia
- Oversedation
- Paradoxical agitation
Key clinical trials
- Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children (NA)
- Virtual Reality to Improve Patient Experience During Endoscopic Mucosal and Submucosal Resection (NA)
- Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit (NA)
- BREATHE Study: Spontaneous Breathing-Preserved Anesthesia and Surgical Strategy for Hospital Recovery in Lung Transplantation (NA)
- Perioperative Recovery Outcomes of a Spontaneous Breathing-Preserving Strategy in Salvage Lung Transplantation (NA)
- Perioperative Recovery Outcomes With a Spontaneous Breathing Strategy in Severely Underweight Lung Transplant Recipients (NA)
- Perioperative Recovery Outcomes With a Spontaneous Breathing Strategy in Older Lung Transplant Recipients (NA)
- Fecal Microbiota Transplantation for the Treatment of ICU Delirium (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Routine sedation and analgesia CI brief — competitive landscape report
- Routine sedation and analgesia updates RSS · CI watch RSS
- Peking University First Hospital portfolio CI
Frequently asked questions about Routine sedation and analgesia
What is Routine sedation and analgesia?
How does Routine sedation and analgesia work?
What is Routine sedation and analgesia used for?
Who makes Routine sedation and analgesia?
What development phase is Routine sedation and analgesia in?
What are the side effects of Routine sedation and analgesia?
Related
- Manufacturer: Peking University First Hospital — full pipeline
- Therapeutic area: All drugs in Anesthesia/Critical Care
- Indication: Drugs for Sedation and analgesia during medical procedures
- Indication: Drugs for Sedation and analgesia in intensive care unit patients
- Compare: Routine sedation and analgesia vs similar drugs
- Pricing: Routine sedation and analgesia cost, discount & access